New preclinical research shows a commonly used Type 2 diabetes drug can improve symptoms in a specific genetic form of ALS and frontotemporal dementia in mice.
In a Nature Medicine news feature, Dr. Michael Okun discusses the challenges that follow some neural implant trials.
New York Times article exploring possible link between some cases of Parkinson’s and exposure to toxic chemicals cites expertise of Dr. Michael Okun.
Dr. Valerie Joers will lead study seeking to identify novel approaches to treat Parkinson’s disease.
Dr. Michael Okun discusses why it's important for patients with Parkinson's disease to alert their hospital caretakers.
New grant will enable 1 Florida ADRC to continue its work with a bolstered focus on advancing understanding of dementias in diverse populations.
New articles offer insight into the importance of multidisciplinary care teams and a patient-centered approach.
In a Neurology Today article, Dr. Michael Okun discusses managing DBS devices during COVID-19.
A UF neurologist and communication scientist have been awarded a $375,000 grant to study how people experience the delivery of such a diagnosis of dementia.
UF neuroscientists uncover a way using neurostimulation to determine whether dysmetria is from tremor or dysfunction of the cerebellum in essential tremor patients.